John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WLL
2476
CALL
DELISTED
Whiting Petroleum Corporation
WLL
| $290K | ﹤0.01% |
171
-737
| -81% | -$1.89M |
|
2477
Utah Medical Products
UTMD
$226M
| $289K | ﹤0.01% |
3,479
-1,831
| -34% | -$161K |
|
|
WCG
2478
DELISTED
Wellcare Health Plans, Inc.
WCG
| $289K | ﹤0.01% |
1,222
-178,331
| -99% | -$47.8M |
|
2479
CALL
Genuine Parts
GPC
$19B
| $288K | ﹤0.01% |
3,000
-11,000
| -79% | -$1.09M |
|
2480
Neurogene
NGNE
$817M
| $288K | ﹤0.01% |
6,671
-735
| -10% | -$35.8K |
|
|
RPT
2481
Rithm Property Trust
RPT
$102M
| $288K | ﹤0.01% |
4,126
+1,184
| +40% | +$89K |
|
2482
Euronet Worldwide
EEFT
$2.66B
| $287K | ﹤0.01% |
2,803
-18,500
| -87% | -$2.05M |
|
|
WAIR
2483
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $287K | ﹤0.01% |
+36,270
| New | +$358K |
|
2484
Cytokinetics
CYTK
$10.8B
| $286K | ﹤0.01% |
45,242
+13,162
| +41% | +$96.6K |
|
2485
CALL
Inogen
INGN
$147M
| $286K | ﹤0.01% |
+2,300
| New | +$379K |
|
2486
PUT
PACCAR
PCAR
$68B
| $286K | ﹤0.01% |
7,500
-12,000
| -62% | -$479K |
|
2487
Community Health Systems
CYH
$419M
| $285K | ﹤0.01% |
+100,983
| New | +$347K |
|
2488
CALL
EQT Corp
EQT
$33.8B
| $285K | ﹤0.01% |
15,100
-31,009
| -67% | -$629K |
|
2489
CALL
Roku
ROKU
$23.7B
| $285K | ﹤0.01% |
9,300
-49,900
| -84% | -$2.35M |
|
2490
CALL
Ashland
ASH
$3.38B
| $284K | ﹤0.01% |
4,000
-10,300
| -72% | -$794K |
|
2491
Enpro
NPO
$6.42B
| $284K | ﹤0.01% |
+4,726
| New | +$313K |
|
2492
KALA BIO
KALA
$15.9M
| $283K | ﹤0.01% |
23
+19
| +475% | +$329K |
|
|
WCG
2493
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
| $283K | ﹤0.01% |
+1,200
| New | +$322K |
|
|
USCR
2494
CALL
DELISTED
U S Concrete, Inc.
USCR
| $282K | ﹤0.01% |
8,000
+1,000
| +14% | +$36.2K |
|
2495
Travelzoo
TZOO
$69.6M
| $281K | ﹤0.01% |
28,613
-5,568
| -16% | -$52.3K |
|
|
MACK
2496
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $281K | ﹤0.01% |
92,627
+20,659
| +29% | +$71.6K |
|
|
FNSR
2497
DELISTED
Finisar Corp
FNSR
| $280K | ﹤0.01% |
+12,974
| New | +$258K |
|
2498
CALL
Abercrombie & Fitch
ANF
$4.84B
| $279K | ﹤0.01% |
13,900
-8,100
| -37% | -$152K |
|
2499
Clean Energy Fuels
CLNE
$346M
| $279K | ﹤0.01% |
162,368
-168,068
| -51% | -$372K |
|
2500
iShares MSCI Japan ETF
EWJ
$22.6B
| $279K | ﹤0.01% |
5,500
+325
| +6% | +$17.8K |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.